AVANOS MEDICAL, INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2025)
$701.20M
Revenue
$-72.90M
Net Income
-1.57
EPS (Diluted)
$76.90M
Free Cash Flow
Profitability
Gross Margin
50.47%
Operating Margin
-8.78%
Net Profit Margin
-10.40%
EBITDA
$6.50M
Returns & Efficiency
Return on Assets (ROA)
-6.79%
Return on Equity (ROE)
-9.37%
Gross Profit
$353.90M
Operating Income
$-61.60M
Financial Health
Total Assets
$1.07B
Total Debt
$90.30M
Debt to Equity
0.38x
Current Ratio
2.15
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$-1.57
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
5405 WINDWARD PARKWAY
SUITE 100 SOUTH ALPHARETTA, GA 30004 |
| Phone | 844-428-2667 |
| Incorporated | DE, US |
| EIN | 464987888 |
| Fiscal Year End | 1231 |
| Stockholders' Equity | $778.20M |
| Cash & Equivalents | $89.80M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-26
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-24
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-24
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-17
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-06
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-03-14
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-02-26
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-10-30
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
50.5%
Operating Margin
-8.8%
Net Margin
-10.4%
ROE
-9.4%
ROA
-6.8%
Leverage & Liquidity
Debt to Equity
0.38
Current Ratio
2.15
Total Debt
$90.30M
Total Assets
$1.07B
Stockholders' Equity
$778.20M
Income Statement (FY 2025)
Revenue
$701.20M
Gross Profit
$353.90M
Operating Income
$-61.60M
Net Income
$-72.90M
EPS (Diluted)
$-1.57
Cash Flow (FY 2025)
Free Cash Flow
$76.90M
Cash & Equivalents
$89.80M
Revenue Growth
1.9%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...